LEADER 04708nam 2200469 450 001 9910502658703321 005 20220706112216.0 010 $a3-030-81100-X 035 $a(CKB)4100000012037511 035 $a(MiAaPQ)EBC6736347 035 $a(Au-PeEL)EBL6736347 035 $a(OCoLC)1272995389 035 $a(PPN)258057831 035 $a(EXLCZ)994100000012037511 100 $a20220625d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aClostridioides Difficile $einfections, risk factors, prevention and treatment /$fHenning Sommermeyer, Jacek Pia?tek 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (96 pages) 311 $a3-030-81099-2 327 $aIntro -- Foreword -- Preface -- Acknowledgments -- Contents -- About the Authors -- Abbreviations -- List of Figures -- List of Tables -- 1: Introduction -- 2: Microbiology -- 2.1 Taxonomy -- 2.2 Genome -- 2.3 Epigenome -- 2.4 Life Cycle of C. difficile During Infection -- 2.4.1 Spore -- 2.4.1.1 Spore Core -- 2.4.1.2 Inner Membrane -- 2.4.1.3 Germ Cell Wall -- 2.4.1.4 Cortex -- 2.4.1.5 Outer Membrane -- 2.4.1.6 Coat and Exosporium -- 2.4.2 Germination -- 2.4.2.1 Germinosome Model -- 2.4.2.2 Lock-and-Key Model -- 2.4.3 Sporulation -- References -- 3: Pathophysiology of C. difficile -- 3.1 Toxins TcdA and TcdB -- 3.2 Genetics of TcdA and TcdB -- 3.3 Pathogenicity Locus -- 3.4 Toxinotypes of C. difficile Isolates -- 3.5 Environmental Signals Regulating Toxin Expression -- 3.6 Mechanism of Action and Functional Domains of TcdA and TcdB -- 3.7 Cell Surface Receptors for TcdA and TcdB -- 3.8 Receptor-Mediated Endocytosis and Membrane Translocation -- 3.9 Modification of Small GTPase Proteins as Host Cell Targets of TcdA and TcdB -- 3.10 Influence of TcdA and TcdB on Cell Physiology -- 3.11 Impact on Cell Morphology -- 3.12 Impact on Small GTPase Signaling Pathways -- 3.13 Role of TcdA and TcdB in Disease -- 3.14 Other Toxins Produced by C. difficile -- 3.15 Toxin Profiles of Clinical Isolates -- References -- 4: Epidemiology -- 4.1 Historical Perspective -- 4.2 Hospital- and Community-Acquired CDI -- 4.3 Hypervirulent C. difficile Strain Ribotype 027 (NAP1/BI) -- 4.4 Other Strains of C. difficile -- 4.5 Dual Strain Infections -- 4.6 CDI in Children -- 4.7 Recurrent CDI -- References -- 5: Risk Factors for CDI -- 5.1 Exposure to Healthcare Institutions -- 5.2 Antibiotics -- 5.3 Proton Pump Inhibitors -- 5.4 Advanced Age as Risk Factor for CDI -- 5.5 Cancer Therapy as Risk Factor for CDI. 327 $a5.6 Other Risk Factors for CDI -- 5.7 Risk Factors for Community-Acquired CDI -- 5.8 Risk Factors for Recurrent CDI -- 5.9 CDI Risk Factors in Children -- References -- 6: Diagnosis of CDI -- References -- 7: Clinical Picture of CDI -- 7.1 From Asymptomatic Carriers to Life-Threatening Presentations -- 7.2 Pseudomembranous Colitis -- References -- 8: Treatment of CDI -- 8.1 Antibiotics-Based Therapy -- 8.1.1 Antibiotics Used for Treatment of CDI -- 8.1.2 AB-Treatment of an Initial, Non-severe CDI Episode in Adults -- 8.1.3 AB-Treatment of a Fulminant Episode of CDI in Adults -- 8.1.4 AB-Treatment of a First or Multiple Recurrence of CDI in Adults -- 8.1.5 AB-Treatment of Non-severe Initial or First Recurrent CDI in Children -- 8.1.6 AB-Treatment of an Initial Episode of Severe CDI in Children -- 8.1.7 AB-Treatment of Second or Greater Episode of Recurrent CDI in Children -- 8.2 Fecal Microbiota Transplantation as Treatment for CDI -- 8.3 Probiotics and Synbiotics as Treatment for CDI -- 8.4 Surgical Treatment of Complicated CDI -- References -- 9: Prophylaxis of CDI -- 9.1 Probiotics and Synbiotics for Prophylaxis of CDI -- 9.2 Bezlotoxumab for the Prevention of Recurrent CDI -- References -- 10: Summary and Discussion -- 10.1 Spores -- 10.2 Pathophysiology -- 10.3 Epidemiology -- 10.4 Risk Factors -- 10.5 Diagnosis -- 10.6 Clinical Picture -- 10.7 Treatment -- 10.8 Prophylaxis -- 10.9 General Outlook. 606 $aClostridium difficile 606 $aClostridi$2thub 608 $aLlibres electrňnics$2thub 615 0$aClostridium difficile. 615 7$aClostridi 676 $a616.3447 700 $aSommermeyer$b Henning$01073687 702 $aPia?tek$b Jacek 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910502658703321 996 $aClostridioides Difficile$92885460 997 $aUNINA LEADER 01396nam a2200349 i 4500 001 991001439169707536 008 060124r19961970us ab 001 0 mul 035 $ab13372671-39ule_inst 040 $aDip.to Studi Giuridici$bita 041 0 $alateng 082 04$a878.6 100 1 $aTacitus, Publius Cornelius$05717 245 10$aAgricola ; Germania ; Dialogus /$cTacitus ; [Agricola] translated by M. Hutton, revised by R. M. Ogilvie ; [Germania] translated by M. Hutton, revised by E. H. Warmington ; [Dialogus] translated by W. Peterson, revised by M. Winterbottom 250 $aRepr. and rev. 260 $aCambridge, Mass. ; London :$bHarvard University press,$c1996 300 $aXV, 357 p., [3] c. di tav. :$bill., c. geogr. ;$c17 cm 440 0$aTacitus ;$v1 440 4$aThe Loeb classical library ;$v35 700 1 $aOgilvie, Robert Maxwell 700 1 $aWinterbottom, Michael 700 1 $aWarmington, Eric Herbert 700 1 $aHutton, Maurice 700 1 $aPeterson, William 740 02$aAgricola 740 02$aGermania 740 02$aDialogus 907 $a.b13372671$b21-09-06$c24-01-06 912 $a991001439169707536 945 $aLE027 R-XXVI/LL TAC A 1$g1$i2027000150465$lle027$o-$pE0.00$q-$rn$so $t0$u0$v0$w0$x0$y.i14182488$z24-01-06 996 $aDialogus de oratoribus$913323 997 $aUNISALENTO 998 $ale027$b24-01-06$cm$da $e-$fmul$gus $h0$i0